Polio vaccine, inactivated.
- Vaccine, meningococcal
1906-1910) showed that college students who live on campus have triple the risk of acquiring meningococcal infection compared with their peers who live off-campus. Among the factors cited for a higher risk of the disease on campus were the relative crowding associated with dormitory residence, alcohol-related behaviors, and exposure to tobacco smoke. The same factors […]
- Vaccine, rubella
A vaccine designed to prevent rubella, or German measles. German measles was once seen merely as a child’s unpleasant rite of passage. It was thought to be a mild malady that was usually over and done in three days. So what? Then an outbreak of rubella began in 1964. It lasted two years and infected […]
- Vaccine, Sabin
The oral polio vaccine (OPV) developed by the Polish-born American microbiologist Albert B. Sabin (1906-93).
- Vaccine, Salk
Vaccine against poliomyelitis named for Dr. Jonas Salk who developed and introduced it in 1955. It was the first type of polio vaccine to become available. It was made by cultivating three strains of the virus separately in monkey tissue. The virus was separated from the tissue, stored for a week, and killed with formaldehyde. […]
Microbial preparations of killed or modified microorganisms that can stimulate an immune response in the body to prevent future infection with similar microorganisms. These preparations are usually delivered by injection.